Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378515097> ?p ?o ?g. }
- W4378515097 endingPage "1346" @default.
- W4378515097 startingPage "1346" @default.
- W4378515097 abstract "Triple-negative breast cancer (TNBC) is an aggressive, fast-growing tumor that is more likely to spread to distant organs. Among women diagnosed with breast cancer, the prevalence of TNBC is 20%, and treatment is currently limited to chemotherapy. Selenium (Se), an essential micronutrient, has been explored as an antiproliferative agent. Therefore, this study aimed to evaluate the effects of exposure to organic (selenomethionine, ebselen, and diphenyl diselenide) and inorganic (sodium selenate and sodium selenite) Se molecules in different breast cell lines. The compounds were tested at 1, 10, 50, and 100 μM for 48 h in the non-tumor breast cell line (MCF-10A) and TNBC derivatives cell lines (BT-549 and MDA-MB-231). The effects of Se on cell viability, apoptotic and necrotic processes, colony formation, and cell migration were analyzed. Exposure to selenomethionine and selenate did not alter the evaluated parameters. However, selenomethionine had the highest selectivity index (SI). The exposure to the highest doses of selenite, ebselen, and diphenyl diselenide resulted in antiproliferative and antimetastatic effects. Selenite had a high SI to the BT cell line; however, the SI of ebselen and diphenyl diselenide was low in both tumoral cell lines. In conclusion, the Se compounds had different effects on the breast cell lines, and additional tests are needed to reveal the antiproliferative effects of Se compounds." @default.
- W4378515097 created "2023-05-28" @default.
- W4378515097 creator A5004749325 @default.
- W4378515097 creator A5024022259 @default.
- W4378515097 creator A5025837353 @default.
- W4378515097 creator A5033908705 @default.
- W4378515097 creator A5071732122 @default.
- W4378515097 creator A5072440860 @default.
- W4378515097 creator A5078927062 @default.
- W4378515097 creator A5080916201 @default.
- W4378515097 date "2023-05-03" @default.
- W4378515097 modified "2023-10-12" @default.
- W4378515097 title "Antiproliferative Effect of Inorganic and Organic Selenium Compounds in Breast Cell Lines" @default.
- W4378515097 cites W1545814905 @default.
- W4378515097 cites W1626095167 @default.
- W4378515097 cites W1719882160 @default.
- W4378515097 cites W2043393762 @default.
- W4378515097 cites W2054727711 @default.
- W4378515097 cites W2060391323 @default.
- W4378515097 cites W2063264712 @default.
- W4378515097 cites W2067038367 @default.
- W4378515097 cites W2072146529 @default.
- W4378515097 cites W2075521812 @default.
- W4378515097 cites W2087981756 @default.
- W4378515097 cites W2090116293 @default.
- W4378515097 cites W2096027508 @default.
- W4378515097 cites W2117001699 @default.
- W4378515097 cites W218010454 @default.
- W4378515097 cites W2407860852 @default.
- W4378515097 cites W2510002611 @default.
- W4378515097 cites W2511612011 @default.
- W4378515097 cites W2725388488 @default.
- W4378515097 cites W2740215864 @default.
- W4378515097 cites W2757231607 @default.
- W4378515097 cites W2766734537 @default.
- W4378515097 cites W2789481433 @default.
- W4378515097 cites W2790571690 @default.
- W4378515097 cites W2791709331 @default.
- W4378515097 cites W2791767507 @default.
- W4378515097 cites W2898488040 @default.
- W4378515097 cites W2905887518 @default.
- W4378515097 cites W2909330821 @default.
- W4378515097 cites W2924501099 @default.
- W4378515097 cites W2930305328 @default.
- W4378515097 cites W2943230929 @default.
- W4378515097 cites W2965236776 @default.
- W4378515097 cites W2981998987 @default.
- W4378515097 cites W2995652422 @default.
- W4378515097 cites W3013275780 @default.
- W4378515097 cites W3023435860 @default.
- W4378515097 cites W3033869790 @default.
- W4378515097 cites W3118790373 @default.
- W4378515097 cites W3121410646 @default.
- W4378515097 cites W3144061486 @default.
- W4378515097 cites W3193955082 @default.
- W4378515097 cites W4206931428 @default.
- W4378515097 cites W4207050061 @default.
- W4378515097 cites W4210380963 @default.
- W4378515097 cites W4211005384 @default.
- W4378515097 cites W4283383104 @default.
- W4378515097 cites W4290786609 @default.
- W4378515097 cites W4293435090 @default.
- W4378515097 cites W4293769381 @default.
- W4378515097 cites W4306382038 @default.
- W4378515097 cites W4307947108 @default.
- W4378515097 cites W4311784387 @default.
- W4378515097 cites W4312223032 @default.
- W4378515097 cites W4318480139 @default.
- W4378515097 cites W4322764004 @default.
- W4378515097 doi "https://doi.org/10.3390/biomedicines11051346" @default.
- W4378515097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37239017" @default.
- W4378515097 hasPublicationYear "2023" @default.
- W4378515097 type Work @default.
- W4378515097 citedByCount "1" @default.
- W4378515097 crossrefType "journal-article" @default.
- W4378515097 hasAuthorship W4378515097A5004749325 @default.
- W4378515097 hasAuthorship W4378515097A5024022259 @default.
- W4378515097 hasAuthorship W4378515097A5025837353 @default.
- W4378515097 hasAuthorship W4378515097A5033908705 @default.
- W4378515097 hasAuthorship W4378515097A5071732122 @default.
- W4378515097 hasAuthorship W4378515097A5072440860 @default.
- W4378515097 hasAuthorship W4378515097A5078927062 @default.
- W4378515097 hasAuthorship W4378515097A5080916201 @default.
- W4378515097 hasBestOaLocation W43785150971 @default.
- W4378515097 hasConcept C109541995 @default.
- W4378515097 hasConcept C121608353 @default.
- W4378515097 hasConcept C126322002 @default.
- W4378515097 hasConcept C178790620 @default.
- W4378515097 hasConcept C185592680 @default.
- W4378515097 hasConcept C190283241 @default.
- W4378515097 hasConcept C2777223630 @default.
- W4378515097 hasConcept C2778004101 @default.
- W4378515097 hasConcept C2778760513 @default.
- W4378515097 hasConcept C2778979269 @default.
- W4378515097 hasConcept C2779138974 @default.
- W4378515097 hasConcept C2779754636 @default.
- W4378515097 hasConcept C2780347965 @default.
- W4378515097 hasConcept C2994423619 @default.